Incannex Healthcare (IXHL) Other Non-Current Assets (2020 - 2022)
Incannex Healthcare (IXHL) posted quarterly Other Non-Current Assets of $991008.0 for Q4 2022, up 1080.33% on a QoQ basis from $83960.0 in Q2 2022.
Incannex Healthcare (IXHL) Other Non-Current Assets (2020 - 2022) Analysis & Trends
Incannex Healthcare (IXHL) has reported Other Non-Current Assets for 3 consecutive years, with $991008.0 the latest figure, recorded in Q4 2022.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $991008.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $991008.0 (changed N/A YoY) and the FY2022 annual result came in at $83960.0, up 132.64% from the prior year.
- Other Non-Current Assets improved to $991008.0 in Q4 2022 per IXHL's latest filing, from $83960.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for IXHL reached as high as $991008.0 in Q4 2022 and fell as low as $36090.0 in Q2 2021.
- A 3-year average of $286830.0 and a median of $60111.0 in 2020 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets retreated 0.47% — and 2022, when it jumped 132.64%.
- Year by year, Other Non-Current Assets stood at $36262.0 in 2020, then slipped by 0.47% to $36090.0 in 2021, then jumped by 2645.94% to $991008.0 in 2022.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $991008.0, $83960.0, and $36090.0 for Q4 2022, Q2 2022, and Q2 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 991,008.00 |
| Jun 30, 2022 | 83,960.00 |
| Jun 30, 2021 | 36,090.00 |
| Jun 30, 2020 | 36,262.00 |